Monday, May 6, 2024, 4:30 p.m.
| Updated 5:23 p.m.
Goodbye to the AstraZeneca covid vaccine. In March, the Swedish-British laboratory requested the withdrawal of this vaccine from the market, which is why the European Commission has proceeded to withdraw the marketing authorization of the injection in the European Union (EU). … a decision that will be effective as of this Tuesday, May 7. The manufacturing company has explained that due to the “multiple updated vaccines” that have been developed to combat covid-19, “there is a surplus of doses available”, which has reduced demand for Vaxzervria “which is no longer manufactured or supplies.
The manufacturer has highlighted the role its laboratory played in the fight against the pandemic. “According to independent estimates, in the first year of use alone, more than 6.5 million lives were saved and more than 3 billion doses were delivered worldwide,” he says. Its withdrawal from the EU comes, however, just a week after the pharmaceutical company admitted in official documents that its vaccine could cause rare adverse effects such as thrombosis, something that led to limiting its use among certain segments of the population.
The journalists of this newspaper are working to expand and complete this information
Access all content the first month for €0.99
